Skip to main content
. 2021 Jan 7;13(1):73. doi: 10.3390/pharmaceutics13010073

Figure 2.

Figure 2

Phenotypical effect of MLo1302. (A) Apoptosis assay in cell lines treated with MLo1302 for 72 h; (B) Proliferation assay (BrdU) in cell lines treated with MLo1302 for 72 h; (C) LDH assay for cytotoxicity in cell lines treated with MLo1302; (D) Real-Time Quantitative PCR (RT-qPCR) for MIB-1 and CDKN1A in MLo1302 treated cell lines. * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001.